Jon St. Germain
Keine laufenden Positionen mehr
Profil
Jon St. Germain held several positions in the medical device industry, including Principal at SCIMED Life Systems, Inc., Vice President of Research & Development at St. Jude Medical LLC, and Senior VP of Operations, Research & Development at CoAxia, Inc. He also served as Chief Operating Officer at ValenTx, Inc. and Vice President of Research & Development at Torax Medical, Inc. Prior to his career in the medical device industry, he earned an undergraduate degree from the University of North Dakota.
Ehemalige bekannte Positionen von Jon St. Germain
Unternehmen | Position | Ende |
---|---|---|
Vascular Science, Inc.
Vascular Science, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Vascular Science, Inc. develops suture-free devices to facilitate coronary artery bypass grafting. The company is based in Minneapolis, MN. The company was founded by Daniel J. Sullivan, Simon H. Stertzer, Rudy A. Mazzocchi. Vascular Science was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on September 27, 1999 for $100 million. | Corporate Officer/Principal | - |
ValenTx, Inc.
ValenTx, Inc. Medical/Nursing ServicesHealth Services ValenTx, Inc. develops therapy solutions. It operates as a medical device company. The firm's therapy solutions focus on treating type-2 diabetes and hypertension. The company was founded by Mitchell Dann in June 2002 and is headquartered in Maple Grove, MN. | Vorstandsvorsitzender | - |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
SCIMED Life Systems, Inc. (Minnesota)
SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Corporate Officer/Principal | - |
CoAxia, Inc.
CoAxia, Inc. Medical/Nursing ServicesHealth Services CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jon St. Germain
University of North Dakota | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Private Unternehmen | 6 |
---|---|
Torax Medical, Inc.
Torax Medical, Inc. Medical SpecialtiesHealth Technology Torax Medical Inc. designs and develops medical devices to treat chronic diseases related to defective sphincter muscles. Its technology platform, Magnetic Sphincter Augmentation (MSA), uses attraction forces to augment weak or defective sphincter muscles to treat gastroesophageal reflux disease (GERD) and fecal incontinence (FI). The firm's products include LINX, a reflux management system for the treatment of GERD; and FENIX, a continence restoration system for the treatment of FI. The company was founded by Todd Berg in 2002 and is headquartered in Shoreview, MN. | Health Technology |
St. Jude Medical LLC
St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
CoAxia, Inc.
CoAxia, Inc. Medical/Nursing ServicesHealth Services CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD. | Health Services |
SCIMED Life Systems, Inc. (Minnesota)
SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Health Technology |
Vascular Science, Inc.
Vascular Science, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Vascular Science, Inc. develops suture-free devices to facilitate coronary artery bypass grafting. The company is based in Minneapolis, MN. The company was founded by Daniel J. Sullivan, Simon H. Stertzer, Rudy A. Mazzocchi. Vascular Science was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on September 27, 1999 for $100 million. | Health Technology |
ValenTx, Inc.
ValenTx, Inc. Medical/Nursing ServicesHealth Services ValenTx, Inc. develops therapy solutions. It operates as a medical device company. The firm's therapy solutions focus on treating type-2 diabetes and hypertension. The company was founded by Mitchell Dann in June 2002 and is headquartered in Maple Grove, MN. | Health Services |